Calif. cosmetics legislation
This article was originally published in The Rose Sheet
Executive Summary
The California Safe Cosmetics Act of 2005 (SB 484) will be addressed by state Senate Appropriations Committee May 26. Introduced by Sen. Carol Migden (D-3rd), bill would authorize the Department of Health Services to investigate cosmetics containing chemicals identified by the state as causing cancer or reproductive toxicity and require manufacturers of such products to submit relevant health effects data and studies as requested. SB 484 cleared the Senate Health Committee last month (1"The Rose Sheet" April 25, 2005, p. 4)...
You may also be interested in...
Calif. Phthalate Ban Defeated But Cosmetic Ingredient Bill Clears Cmte.
One of two bills introduced by California legislators seeking to regulate cosmetic ingredients has survived a first round of committee hearings. The California Safe Cosmetics Act of 2005 cleared the Senate Health Committee (6-4) April 20, while The Phthalates Free Cosmetics Act was defeated a day earlier during an Assembly Health Committee meeting
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.